Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.8%

4 terminated out of 34 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results71% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (9)
P 1 (2)
P 2 (8)
P 3 (3)

Trial Status

Unknown11
Completed10
Terminated4
Active Not Recruiting3
Recruiting3
Not Yet Recruiting3

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT03102229Not ApplicableCompleted

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

NCT07072728Phase 2Recruiting

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT05311176Phase 2Terminated

A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)

NCT03949907Not ApplicableTerminatedPrimary

Early IntraVenous Administration of Nutritional Support

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT06940778Active Not Recruiting

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

NCT05041335Not ApplicableNot Yet Recruiting

Wet Heparinized Suction for Abdominal Cancer

NCT03301493Completed

Genomic Testing and Resulting Medical Decisions

NCT05804331RecruitingPrimary

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

NCT06711939Not Yet Recruiting

Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)

NCT03133286Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT05688761CompletedPrimary

Nordic Gastric and Esophageal Tumor Study

NCT03129139Phase 1Unknown

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

NCT03347162Active Not Recruiting

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

NCT05747482Not ApplicableNot Yet RecruitingPrimary

Omentectomy vs Omental Preservation in Resectable Cancer

NCT03775525Phase 1Unknown

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

NCT05088304CompletedPrimary

GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer

NCT03541629CompletedPrimary

Audit of the Spanish EURECCA Esophagogastric Cancer Registry

NCT03719716Not ApplicableCompleted

Early Support in Primary Care for People Starting Treatment for Cancer

Scroll to load more

Research Network

Activity Timeline